Core Scientific, Tranche Stock Return On Asset
| CORZZ Stock | 18.19 0.69 3.94% |
Core Scientific, Tranche fundamentals help investors to digest information that contributes to Core Scientific,'s financial success or failures. It also enables traders to predict the movement of Core Stock. The fundamental analysis module provides a way to measure Core Scientific,'s intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Core Scientific, stock.
Return On Assets is likely to drop to -0.36 in 2024. Core | Return On Asset |
Core Scientific, Tranche Company Return On Asset Analysis
Core Scientific,'s Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Core Scientific, Return On Asset | 0.0122 |
Most of Core Scientific,'s fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Core Scientific, Tranche is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Core Return On Asset Driver Correlations
Understanding the fundamental principles of building solid financial models for Core Scientific, is extremely important. It helps to project a fair market value of Core Stock properly, considering its historical fundamentals such as Return On Asset. Since Core Scientific,'s main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Core Scientific,'s historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Core Scientific,'s interrelated accounts and indicators.
Click cells to compare fundamentals
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Core Intangible Assets
Intangible Assets |
|
Based on the latest financial disclosure, Core Scientific, Tranche has a Return On Asset of 0.0122. This is 100.42% lower than that of the Technology sector and 75.6% lower than that of the Software - Infrastructure industry. The return on asset for all United States stocks is 108.71% lower than that of the firm.
Core Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Core Scientific,'s direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Core Scientific, could also be used in its relative valuation, which is a method of valuing Core Scientific, by comparing valuation metrics of similar companies.Core Scientific, is currently under evaluation in return on asset category among its peers.
Core Fundamentals
| Return On Asset | 0.0122 | ||||
| Profit Margin | (0.49) % | ||||
| Operating Margin | 0.07 % | ||||
| Number Of Shares Shorted | 44.01 K | ||||
| Revenue | 502.4 M | ||||
| EBITDA | (63.12 M) | ||||
| Net Income | (246.49 M) | ||||
| Total Debt | 865.54 M | ||||
| Cash Flow From Operations | 65.11 M | ||||
| Number Of Employees | 286 | ||||
| Total Asset | 712.16 M | ||||
| Retained Earnings | (2.42 B) | ||||
| Working Capital | (391.41 M) | ||||
| Net Asset | 712.16 M |
About Core Scientific, Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Core Scientific, Tranche's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Core Scientific, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Core Scientific, Tranche based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Core Stock Analysis
When running Core Scientific,'s price analysis, check to measure Core Scientific,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Scientific, is operating at the current time. Most of Core Scientific,'s value examination focuses on studying past and present price action to predict the probability of Core Scientific,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Core Scientific,'s price. Additionally, you may evaluate how the addition of Core Scientific, to your portfolios can decrease your overall portfolio volatility.